Pro Lab Marketing receives distribution rights for Vivakor’s VivaThermic cryovials in India

NewsGuard 100/100 Score

Vivakor, Inc. (OTCBB: VIVK) announces distribution of its VivaThermic products to the rapidly growing biotech/biopharma industries in India through its agreement with Pro Lab Marketing Pvt. Ltd. This agreement gives Pro Lab Marketing distribution rights for Vivakor’s VivaThermic cryovials in India. Pro Lab Marketing, based in New Delhi, is a well-established Indian supplier of biotechnology-related products and equipment throughout India. “We are impressed with the VivaThermic products and their outstanding performance,” stated Mr. J.K. Jain, Managing Director of Pro Lab Marketing. He continues, “Through our distribution agreement with Vivakor we will introduce the VivaThermic products to our customers throughout India who will benefit greatly from use of this technology."

Vivakor’s CEO, Dr. Tannin Fuja, indicated that, “The Indian biotechnology industry is gaining significant momentum and India figures to become a prominent player in the global biotech market. A number of India’s biotech firms are beginning to emerge as major global players.” The budding of an innovative Indian biotech sector will hold major implications for the global industry and for improving both health and prosperity in the developing world.

Pro Lab Marketing, which distributes products for numerous reputable US and international manufacturers, supplies this growing Indian industry with equipment and supplies. A recent report, "Booming Biotech Market in India," valued the Indian biotechnology market at US$ 2.86 Billion in 2007-08, and projects an annual growth rate of 30% in near future. The study also reports that Biopharma remains India's biggest sector, accounting for nearly 70% of the total revenues in 2007-08 and is expected to be worth US$ 5.7 billion by 2012-2013. The future of the bio-supplier industry in India looks very bright and Vivakor is pleased to introduce its superior VivaThermic cryovials to its Indian customers through Pro Lab Marketing.

http://www.vivakor.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy